Skip to content

The effectiveness of High-Intensity Laser Therapy (at 1580 Joules) in de Quervains tenosynovitis: A randomized double-blinded controlled trial

The effectiveness of High-Intensity Laser Therapy (at 1580 Joules) in de Quervains tenosynovitis: A randomized double-blinded controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210712004
Enrollment
36
Registered
2021-07-12
Start date
2021-07-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual analogue scale and lateral pinch strength of patient diagnosed with de Quervain&#039

Interventions

Patient will receive 3 treatment sessions of high intensity laser therapy(1580 Joules) per week for 3 weeks. One session consists of Bio-stimulation mode and analgesia mode. Both of therapeutic modes
Experimental Device,Sham Comparator Device
High Intensity Laser Therapy ,Control group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosis of de Quervain's tenosynovitis -The 1st dorsal compartment pain and tenderness -Symptom provoked by thumb extension and abduction -Finkelstein's test: positive 2.Unilateral affected wrist and developed more than 1 month 3.Moderate to severe pain (VAS 40-80/100 mm) 4.Informed consent 5.Free from any NSAID medication for 2 weeks

Exclusion criteria

Exclusion criteria: 1. History of others wist and distal forearm disorders 2. Skin problems at the affected wrist 3. History of surgery or trauma or deformity of the affected limb 4. Neurological disease(e.g.cervical spondylosis with radiculopathy) 5. Systemic infection or rheumatologic disease 6. Contraindication of HILT(e.g. pregnancy, tumor, uncontrolled Diabetes Mellitus etc.) 7. Allergic to acetaminophen 8. On medication that has drug interaction with acetaminophen 9. History of local steroid injection at affected area in 3 months 10. Cannot wear splint due to allergic to splint or other reasons

Design outcomes

Primary

MeasureTime frame
Pain score pre-treatment, within 48 hours post-last-treatment and 3 weeks post-last-treatment Visual analogue scale(VAS),Lateral pinch strength pre-treatment, within 48 hours post-last-treatment and 3 weeks post-last-treatment Jamar pinch gauge(Kg.)

Secondary

MeasureTime frame
Functional outcome pre-treatment, within 48 hours post-last-treatment and 3 weeks post-last-treatment Patient-rated wrist/hand evaluation-Thai (PRW/HE -Thai),Adverse Event during entire study Medical record document

Countries

Thailand

Contacts

Public ContactNutthakun Sumanapun

Department of Rehabilitation Medicine, Faculty of Medicine, Chulalongkorn University

ntk_muly@hotmail.com0871931308

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026